The DOI matches its Crossref record; 294 of the 294 references it cites were found in a registry or an index.
Design, optimization, and nanotechnology of antimicrobial peptides: From exploration to applications
Abstract
Abstract Antibiotic resistance caused by antibiotic abuse, especially the emergence of multi-drug resistant bacteria, poses a serious threat to human health, and makes it imperative to find novel antibiotic alternatives. Antimicrobial peptides (AMPs) as a kind of biomaterials have been revolutionarily evolved into formidable candidates due to their unique non-specific membrane rupture mechanism. However, natural AMPs exist a series of problems including weak bioactivity, high toxicity, and immature stability, which seriously hindered their application. Fortunately, in recent years, the progress of molecular design and optimization strategies, and the fast-rising nanotechnology, have shown the potential to improve the biological and chemical properties of AMPs, which make the application of AMPs possible. Herein, we first review the progress in the design and optimization strategies of AMPs, which lay a theoretical foundation for the development of peptide-based antimicrobial nanomaterials and provided more effective antibiotic alternatives. Secondly, we summarized the construction strategy and biological effects of peptide-based antimicrobial nanomaterials. Lastly, the applications of peptide-based antimicrobial drugs were introduced, and the current challenges and future perspectives in this field are proposed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rudd, K. E., Johnson, S. C., Agesa, K. M., Shackelford, K. A., Tsoi, D., Kievlan, D. R., Colombara, D. V., Ikuta, K. S., Kissoon, N., Finfer, S., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(19)32989-7 · Cited by 7,971
Biofilms: Survival Mechanisms of Clinically Relevant Microorganisms
Donlan, R. M., & Costerton, J. W. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.2.167-193.2002 · Cited by 6,644
Biofilms: an emergent form of bacterial life
Flemming, H.-C., Wingender, J., Szewzyk, U., Steinberg, P., Rice, S. A., & Kjelleberg, S. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.94 · Cited by 5,979
Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?
Brogden, K. A. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1098 · Cited by 5,829
On the size of the active site in proteases. I. Papain
Schechter, I., & Berger, A. (1967) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(67)80055-x · Cited by 5,204
Antibiotic resistance-the need for global solutions
Laxminarayan, R., Duse, A., Wattal, C., Zaidi, A. K. M., Wertheim, H. F. L., Sumpradit, N., Vlieghe, E., Hara, G. L., Gould, I. M., Goossens, H., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70318-9 · Cited by 4,439
Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies
Hancock, R. E. W., & Sahl, H.-G. (2006) · Nature Biotechnology · doi:10.1038/nbt1267 · Cited by 4,208
Molecular mechanisms of antibiotic resistance
Blair, J. M. A., Webber, M. A., Baylay, A. J., Ogbolu, D. O., & Piddock, L. J. V. (2015) · Nature Reviews Microbiology · doi:10.1038/nrmicro3380 · Cited by 4,092
Strategies in the design of nanoparticles for therapeutic applications
Petros, R. A., & DeSimone, J. M. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd2591 · Cited by 3,651
APD3: the antimicrobial peptide database as a tool for research and education
Wang, G., Li, X., & Wang, Z. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1278 · Cited by 2,388
Cited by
Fu, H., Tan, P., Wang, R., Li, S., Liu, H., Yang, Y., & Wu, Z. (2022) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2021.127494 · Cited by 349
Self-citationPhysiological Functions of Threonine in Animals: Beyond Nutrition Metabolism
Tang, Q., Tan, P., Ma, N., & Ma, X. (2021) · Nutrients · doi:10.3390/nu13082592 · Cited by 212
Self-citationZhao, J., Hu, J., & Ma, X. (2021) · Nutrients · doi:10.3390/nu13082756 · Cited by 17
Self-citation
Metadata
- Authors
- Tan, P., Fu, H., & Ma, X.
- Venue
- Nano Today
- Publisher
- Elsevier BV
- Published
- 2021-08
- Volume
- 39
- Pages
- 101229
- ISSN
- 1748-0132 (ISSN-L)
- OpenAlex
- W3178671025
- Cited by
- 351
- References
- 294
- FWCI
- 30.06
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Design, optimization, and nanotechnology of antimicrobial peptides: From exploration to applications. https://app.cochat.ai/papers/10.1016/j.nantod.2021.101229
- The paper
- Tan, P., Fu, H., & Ma, X. (2021). Design, optimization, and nanotechnology of antimicrobial peptides: From exploration to applications. Nano Today. https://doi.org/10.1016/j.nantod.2021.101229
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.